Immune-mediated liver injury of the cancer therapeutic antibody catumaxomab targeting EpCAM, CD3 and Fcγ receptors.
| Image |  |
|---|---|
| Description | scientific article published on 04 April 2016 |
| Author/s |
author: Jürgen Borlak Florian Länger |
| Publication date | May 1, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |